Syneos Health, Inc.
SYNH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $3,777 | $10,666 | $7,097 | $6,162 |
| - Cash | $112 | $106 | $272 | $164 |
| + Debt | $2,899 | $3,079 | $3,215 | $2,920 |
| Enterprise Value | $6,564 | $13,638 | $10,040 | $8,918 |
| Revenue | $5,393 | $5,213 | $4,416 | $4,676 |
| % Growth | 3.5% | 18.1% | -5.6% | – |
| Gross Profit | $1,254 | $1,218 | $1,018 | $1,030 |
| % Margin | 23.3% | 23.4% | 23% | 22% |
| EBITDA | $700 | $656 | $578 | $567 |
| % Margin | 13% | 12.6% | 13.1% | 12.1% |
| Net Income | $266 | $235 | $193 | $131 |
| % Margin | 4.9% | 4.5% | 4.4% | 2.8% |
| EPS Diluted | 2.54 | 2.24 | 1.83 | 1.25 |
| % Growth | 13.4% | 22.4% | 46.4% | – |
| Operating Cash Flow | $427 | $450 | $425 | $318 |
| Capital Expenditures | -$93 | -$57 | -$50 | -$64 |
| Free Cash Flow | $334 | $393 | $375 | $255 |